Labeling blood and other samples at the time they are collected improves patient safety and helps prevent a host of problems related to misidentification — including many of the estimated 160,900 adverse events that occur in U.S. hospitals annually because of sample identification errors. There is a strong and growing body of evidence within medical literature that creating specimen identification labels on demand at the patient bedside with a mobile printer can significantly reduce errors. The Joint Commission’s National Patient Safety Goals (NPSG) advocate the use of two patient-specific identifiers, such as name and birthdate, whenever taking blood or other samples from a patient, and to label the sample collection container in the presence of the patient.
In February 2004, the FDA issued a Draft Guidance requiring the electronic submission of labeling content to be provided in an XML-based format called Structured Product Labeling (SPL). The purpose of this white paper is for the reader to gain an understanding and prepare for the FDA's new electronic labeling submission standard.
Wherever there is a label on a product, there is a potential need for printer applicators. Download this whitepaper now for a thorough analysis of the complete labeling requirement, from part production to end user application, which must to be completed to determine the correct printer applicator.
Credit Union Times is the nation's leading independent source for breaking news and analysis for credit union leaders. For more than 20 years, Credit Union Times has set the standard for editorial excellence and ethical, straight-forward reporting.